Physician profile
Terrence P Wright
NPI 1124056643
$3,492.87
in general payments reported to CMS, 2019-2025
32 companies · $15.92 in 2025
The $15.92 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2020: $372 · 2021: $380 · 2022: $363 · 2023: $830 · 2024: $609 · 2025: $15.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $585.00 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $583.64 | 2020-2024 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $480.58 | 2019-2024 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $259.82 | 2019-2024 | |
| Lilly USA, LLC | $167.03 | 2019-2024 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $151.56 | 2020-2024 | Trintellix, Glassia |
| Glaxosmithkline, LLC. | $147.40 | 2019-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $142.69 | 2019-2024 | Eliquis, Camzyos |
| Amgen INC. | $123.80 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $102.97 | 2019-2023 | Vaxneuvance, M-M-R II, Vaxelis |
| Novartis Pharmaceuticals Corporation | $84.14 | 2019-2022 | |
| Allergan, INC. | $81.99 | 2020 | |
| Astellas Pharma US INC | $80.47 | 2019-2024 | Veozah |
| Janssen Pharmaceuticals, INC | $79.94 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.04 | 2021-2023 | Spiriva Respimat, Stiolto Respimat |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $42.58 | 2020-2023 | |
| Supernus Pharmaceuticals, INC. | $35.76 | 2022-2023 | Qelbree |
| Sanofi-Aventis U.S. LLC | $29.36 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $26.05 | 2019-2020 | |
| Axsome Therapeutics, INC. | $20.87 | 2023 | Sunosi |
| Abbott Laboratories | $19.48 | 2019 | |
| Jazz Pharmaceuticals INC. | $19.17 | 2021 | |
| Hologic Sales and Service, LLC | $19.15 | 2023 | Myosure Tissue Removal Device |
| Philips North America LLC | $18.24 | 2021 | |
| Aimmune Therapeutics, INC. | $15.92 | 2025 | Zenpep |
| Xeris Pharmaceuticals, INC. | $15.44 | 2023 | Keveyis |
| Exact Sciences Corporation | $15.21 | 2024 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.11 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.03 | 2023 | Xifaxan |
| Shire North American Group INC | $14.90 | 2019 | |
| Mylan Specialty L.P. | $13.90 | 2020 | |
| Cranial Technologies, INC | $11.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrence Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.